Dry skin woes? Research suggests dupilumab may cause skin and eye problems in young children with atopic dermatitis. More studies needed to understand these risks. Learn more about the potential side effects on our research page: Dupilumab Safety Study
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Dry skin woes? Research suggests dupilumab may cause skin and eye problems in young children with atopic dermatitis. More studies needed to understand these risks. Learn more about the potential side effects on our research page: Dupilumab Safety Study
In VitroCell or tissue culture experiments. No human or animal data.Published: June 8, 2026
Hydrogel May Help Treat Wound Infections and Reduce Antibiotic Pollution
Researchers created a special hydrogel that can absorb antibiotics from wastewater and release them in a controlled way when exposed to near-infrared light. In lab experiments, this hydrogel showed promise in treating wound infections by killing bacteria and promoting healing. The hydrogel's effects were seen in experiments with two types of bacteria.
Why it matters: This research may help us better understand how to treat wound infections and reduce the environmental impact of antibiotic pollution.
This study was conducted in a lab and only tested the hydrogel's effects on bacteria in a controlled environment. Further research is needed to confirm its effectiveness in real-world settings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Dry SkinPublished: June 8, 2026
Dupilumab safety in young children with atopic dermatitis studied
Researchers analyzed reports of side effects in young children with atopic dermatitis who took dupilumab, a medication for severe skin condition. They found that many children experienced skin and eye problems, such as dry skin and eye irritation, within a few weeks of starting treatment. The study suggests that dupilumab may have some risks for young children, but more research is needed to understand these risks.
Why it matters: This study may help doctors and parents understand the potential risks of dupilumab in young children with atopic dermatitis.
This study analyzed reports from a database, not a controlled trial, and the results may not be representative of all children who take dupilumab.
Small Human StudySmall or uncontrolled human study. Results are preliminary.RetinolRedness / Facial RednessPublished: June 7, 2026
Apremilast May Help Treat Rare Skin Condition
Researchers studied apremilast, a medication, for treating a rare skin condition called acrodermatitis continua of Hallopeau. They found that in a small group of patients, apremilast may help reduce skin symptoms and joint pain. However, more research is needed to confirm these findings.
Why it matters: This study may help doctors find new treatment options for patients with this rare skin condition.
This study included only two cases and eight cases from literature, and the results may be influenced by publication bias. The study also found that one patient did not respond well to apremilast.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: June 6, 2026
Low-Level Light Therapy May Help with Postherpetic Neuralgia
Researchers studied low-level light therapy (LLLT) for treating postherpetic neuralgia, a complication of herpes zoster that causes long-term skin discomfort. They found that LLLT may reduce pain and inflammation, and promote nerve repair. However, more research is needed to confirm these findings.
Why it matters: This study may help us understand how LLLT affects skin and nerve health, which could lead to new treatments for skin conditions.
The review synthesizes existing evidence, but the original studies may have limitations such as small sample sizes or short durations.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Redness / Facial RednessPublished: June 6, 2026
Intense Pulsed Light vs. Diode Laser for Hair Removal: A Study
Researchers studied the effectiveness and safety of intense pulsed light (IPL) and diode laser (DL) for removing hair from the armpits of women with fair to medium skin. Both treatments reduced hair growth, but diode laser showed more favorable results in the long term. However, it also caused more discomfort and temporary side effects.
Why it matters: This study may help people understand the pros and cons of using IPL or DL for hair removal, but more research is needed to confirm these findings.
This study had a small sample size and only followed participants for 7 months after treatment.
Animal StudyResults in animals only. May or may not translate to humans.AcnePublished: June 5, 2026
Cinnamic Acid Bigel May Help Reduce Acne Inflammation
Researchers studied a new topical treatment for acne that combines cinnamic acid with a bigel system. They found that this treatment may help reduce inflammation and kill bacteria that cause acne. The study was conducted in a lab and involved animal studies.
Why it matters: This research may lead to new treatments for acne that are more effective and have fewer side effects.
This study was conducted in a lab and involved animal studies, so its results may not translate to humans. Further research is needed to confirm these findings.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.